Resultats de la cerca - Lode, Holger
- Mostrar 1 - 20 resultats de 43
- Anar a la pàgina següent
-
1
-
2
-
3
Management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage 4 neuroblastoma: A case report per Lode, Holger N., Henze, Günter, Siebert, Nikolai, Ehlert, Karoline, Barthlen, Winfried
Publicat 2019Text -
4
-
5
-
6
-
7
In vitro response of THP-1 derived macrophages to antimicrobially effective PHMB-coated Ti6Al4V alloy implant material with and without contamination with S. epidermidis and P. aer... per Zwicker, Paula, Schmidt, Thomas, Hornschuh, Melanie, Lode, Holger, Kramer, Axel, Müller, Gerald
Publicat 2022Text -
8
GM‐CSF as successful salvage therapy of metamizole (dipyrone)‐induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent per Winkler, Annegret, Kietz, Silke, Bahlmann, Hagen, Jafarzade, Gunel, Lode, Holger N., Heckmann, Matthias
Publicat 2016Text -
9
Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice per Marx, Madlen, Zumpe, Maxi, Troschke-Meurer, Sascha, Shah, Diana, Lode, Holger N., Siebert, Nikolai
Publicat 2018Text -
10
-
11
Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma per Lode, Holger N., Dreier, Torsten, Xiang, Rong, Varki, Nissi M., Kang, Angray S., Reisfeld, Ralph A.
Publicat 1998Text -
12
Reduction of CD11b(+) myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD(2) antibody ch14.18/CHO per Siebert, Nikolai, Zumpe, Maxi, von Lojewski, Leon, Troschke-Meurer, Sascha, Marx, Madlen, Lode, Holger N.
Publicat 2020Text -
13
-
14
Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study per Kersten, Ines, Lange, Anja Erika, Haas, Johannes Peter, Fusch, Christoph, Lode, Holger, Hoffmann, Wolfgang, Thyrian, Jochen Rene
Publicat 2014Text -
15
Synergy between an antiangiogenic integrin α(v) antagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases per Lode, Holger N., Moehler, Thomas, Xiang, Rong, Jonczyk, Alfred, Gillies, Stephen D., Cheresh, David A., Reisfeld, Ralph A.
Publicat 1999Text -
16
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction per Lode, Holger N., Xiang, Rong, Pertl, Ursula, Förster, Elisabeth, Schoenberger, Stephen P., Gillies, Stephen D., Reisfeld, Ralph A.
Publicat 2000Text -
17
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy per Shabat, Doron, Lode, Holger N., Pertl, Ursula, Reisfeld, Ralph A., Rader, Christoph, Lerner, Richard A., Barbas, Carlos F.
Publicat 2001Text -
18
Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients per Lode, Holger, Siebert, Nikolai, Kietz, Silke, Müller, Ina, Schuster, Manfred, Janzek, Evelyne, Wiederkum, Susanne, Mutschlechner, Oliver, Loibner, Hans
Publicat 2013Text -
19
Generation and Characterization of a Human/Mouse Chimeric GD(2)-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma per Eger, Christin, Siebert, Nikolai, Seidel, Diana, Zumpe, Maxi, Jüttner, Madlen, Brandt, Sven, Müller, Hans-Peter, Lode, Holger N.
Publicat 2016Text -
20
First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma per Spasov, Neofit J., Dombrowski, Frank, Lode, Holger N., Spasova, Mariya, Ivanova, Liliya, Mumdjiev, Ivan, Burnusuzov, Hassan, Siebert, Nikolai
Publicat 2022Text